Skip to main content

Logilia Disease Interactions

There are 2 disease interactions with Logilia (ulipristal).

Moderate

Ulipristal (applies to Logilia) hepatic impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

No studies have been conducted to evaluate the effect of hepatic disease on the disposition of ulipristal. Caution is recommended when using this agent in patients with liver disease.

References

  1. (2022) "Product Information. Ella (ulipristal)." Afaxys Inc.
Moderate

Ulipristal (applies to Logilia) renal impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction

No studies have been conducted to evaluate the effect of renal disease on the disposition of ulipristal. Caution is recommended when using this agent in patients with renal impairment.

References

  1. (2022) "Product Information. Ella (ulipristal)." Afaxys Inc.

Logilia drug interactions

There are 203 drug interactions with Logilia (ulipristal).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer